Clinical trial
Dose-Range Finding Study for MK0893 (0893-008)
NCT00479466 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00479466 |
|---|---|
| Title | Dose-Range Finding Study for MK0893 (0893-008) |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose-Range Finding Study of MK0893 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | MK0893, Metformin, Placebo to MK0893, Placebo to Metformin |
| Enrollment | 342 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 28, 2007 |
| Last update posted | Sep 9, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: